LifeMD, Inc. (LFMD) Form 10-Q — Nov 12, 2026
LifeMD reported Q3 2026 telehealth revenue of $44.6 million, down about 6.5% from $47.7 million a year earlier, with a quarterly net loss of $4.5 million and a nine-month net loss of $20.6 million versus $5.2 million in the prior-year period. The company disclosed a revision of previously issued 2024, 2025 and 2026 financial statements to correct errors in how pharmacy-related revenue and expenses were recorded, cutting 2025 net income by $1.5 million and widening 2024 losses by $3.3 million.
Key figures
- Revenue
- 44625086
- Total Debt
- 0
- Total Assets
- 66285031
- Cash Position
- 21921769
- Shares Outstanding
- 48333837
- Avenue maturity
- May 1, 2030
- Q3 2025 revenue
- 47727942
- Accounts payable
- 37736899
- Avenue loan amount
- 12500000
- Nine month revenue
- 142048848
- Accumulated deficit
- 256343292
- Atm capacity remaining
- 44600000
- Avenue loan interest rate
- greater of Prime + 4.50% or 11.50%
- Active patient subscribers
- 350000
AI analysis
Red flags7 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.